XENT
Intersect ENT, Inc
XENT
XENT
Delisted
XENT was delisted on the 12th of May, 2022.
138 hedge funds and large institutions have $808M invested in Intersect ENT, Inc in 2018 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 50 increasing their positions, 42 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
22% less capital invested
Capital invested by funds: $1.03B → $808M (-$227M)
51% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 43
Holders
138
Holding in Top 10
1
Calls
$24.2M
Puts
$17.2M
Top Buyers
| 1 | +$32.4M | |
| 2 | +$26.6M | |
| 3 | +$19.6M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$9.23M |
| 5 |
BlackRock
New York
|
+$8.54M |
Top Sellers
| 1 | -$36.7M | |
| 2 | -$28.1M | |
| 3 | -$15.1M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$14.2M |
| 5 |
Renaissance Technologies
New York
|
-$10.4M |